CHRS Member Lead High Impact Publications
- Sapp JL, Tang ASL, Parkash R, et al. Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia. N Engl J Med.
- Knops RE, Lloyd MS, Roberts PR, et al. A Modular Communicative Leadless Pacing-Defibrillator System. N Engl J Med. 2024;391(15):1402-1412.
- Oraii A, McIntyre WF, Parkash R, et al. Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. JAMA Cardiol. 2024;9(6):545-555.
- Sapp JL, Sivakumaran S, Redpath CJ, et al. Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure. N Engl J Med. 2024;390(3):212-220.
- Healey JS, Lopes RD, Granger CB, et al. Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation. N Engl J Med. 2024;390(2):107-117.
- Johnson LS, Mente A, Joseph P, et al. Sodium Intake and Incident Atrial Fibrillation in Individuals With Vascular Disease. JAMA Netw Open. 2024;7(7):e2421589.
- Conen D, Ke Wang M, Popova E, et al. Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial. Lancet. 2023;402(10413):1627-1635.
- Wilkoff BL, Filippatos G, Leclercq C, et al. Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial [published correction appears in Lancet. 2023 Sep 30;402(10408):1132.
- Boursalie S, MacIntyre C, Sapp JL, et al. Disparities in Referral and Utilization of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death. Can J Cardiol. 2023;39(11):1610-1616.
- Andrade JG, Deyell MW, Macle L, et al. Progression of Atrial Fibrillation after Cryoablation or Drug Therapy. N Engl J Med. 2023;388(2):105-116.
- Han HC, Wang J, Birnie DH, et al. Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality. JAMA Cardiol. 2023;8(5):484-491.
- Nair GM, Birnie DH, Nery PB, et al. Standard vs Augmented Ablation of Paroxysmal Atrial Fibrillation for Reduction of Atrial Fibrillation Recurrence: The AWARE Randomized Clinical Trial. JAMA Cardiol. 2023;8(5):475-483.
- Force ZM, Parkash R, Tang A, et al. Health Security Perceptions: Initial Psychometric Analysis of the Construct of Health Security in Chronic Illness Among Patients With a Cardiac Device. CJC Open. 2023;5(9):704-708.
- Greene A, Sapp J, Hirsch G, et al. Cardiovascular Outcomes in Nova Scotia During the Early Phase of the COVID-19 Pandemic. CJC Open. 2022;4(3):324-336.
- Whitlock RP, Belley-Cote EP, Paparella D, et al. Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke. N Engl J Med. 2021;384(22):2081-2091.
- Andrade JG, Wells GA, Deyell MW, et al. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. N Engl J Med. 2021;384(4):305-315.
- Stiell IG, Eagles D, Nemnom MJ, et al. Adverse Events Associated With Electrical Cardioversion in Patients With Acute Atrial Fibrillation and Atrial Flutter. Can J Cardiol. 2021;37(11):1775-1782.
- Yee R, Karim SS, Bashir J, et al. Canadian Heart Rhythm Society Task Force Report on Physician Training and Maintenance of Competency for Cardiovascular Implantable Electronic Device Therapies: Executive Summary. Can J Cardiol. 2021;37(11):1857-1860.
- Gladstone DJ, Wachter R, Schmalstieg-Bahr K, et al. Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial. JAMA Cardiol. 2021;6(5):558-567.
- McIntyre WF, Wang MK, Conen D. Balancing the Risks and Benefits of Oral Anticoagulant Use in Patients With Postoperative Atrial Fibrillation. Can J Cardiol. 2021;37(6):938.e11.